Transcriptomic Profiling of Patient Derived Alternative Lengthening of Telomeres (ALT) and Non-MYCN-Amplified Neuroblastoma Cell Lines

ANALYTE_TYPE - Analyte Type (phv00491501.v1.p1)
CONSENT - Consent group as determined by DAC (phv00491496.v1.p1)
HISTOLOGICAL_TYPE - Cell or tissue type or subtype of sample (phv00491502.v1.p1)
IS_TUMOR - Tumor status (phv00491503.v1.p1)
PHASE_OF_THERAPY - Phase of therapy at establishment (phv00491508.v1.p1)
RISK - COG risk classification (phv00491507.v1.p1)
SAMPLE_ID - Sample ID (phv00491500.v1.p1)
SAMPLE_ID - Sample ID (phv00491499.v1.p1)
SAMPLE_TYPE - Type of sample (phv00491505.v1.p1)
SUBJECT_ID - Subject ID (phv00491495.v1.p1)
SUBJECT_ID - Subject ID (phv00491498.v1.p1)
TUMOR_STAGE - Tumor stage of sample (phv00491506.v1.p1)